Yes Coleah Penley Ayers ... well done.

That's one of your important jobs ... trivialize and minimize the harm
.... mock the cancers found and blame everythng but the chips.

You learned well watching your Mentor and Business Partner, O'leary,
give the junkscience propaganda.

Keep the corporations in business as long as possible so they can make
as much as possible before all the damning facts come to light.

Put that great big fat ass of yours (you love to push into my life)
all over this emerging science ... use your tonnage and huge mouth to
smother the facts with industry denials.

Verichip (and corporate PR mouths like you) use the identical denials
as have been used against the breast implanted community of women ...
and hid studies ... against identical to your Corporate Disinformation
Campaign.

More facts:
http://blog.wired.com/27bstroke6/200...-bulldog-.html

French Bulldog at Heart of RFID Tumor Story
By Kim Zetter September 10, 2007 | 5:31:55 PMCategories: RFID
A nine-year-old French bulldog named Leon was the catalyst for the
enterprising Associated Press story published this weekend about the
link between RFID chips and cancer -- which comes just a week after
the California senate passed a bill prohibiting the forced implanation
of chips in humans.

Leon (pictured at right) was diagnosed in 2004 with a tumor and later
died. His Canadian owner "Jeanne," believing the RFID chip embedded in
Leon's neck for identification purposes was linked to her pet's death,
decided to seek answers about why the tumor had attached itself to the
glass-encapsulated RFID chip.

The Italian researchers she found to examine tissue from her dog
released a paper in 2006 that suggests a connection between the chip
and Leon's tumor and revealed that other studies had been conducted
previously that also showed tumors occurring in rats and cats that had
been microchipped. The tumors formed between 1 month and 3 years after
the chips were implanted and seemed to spring up around areas of
inflammation created by the microchip.

As the AP article shows, however, VeriChip, the company that pushed
for FDA approval of the chips in 2005 for medical and identification
purposes, failed to disclose the existence of such studies to the FDA.

VeriChip told the Associated Press that it had not been aware of any
previous studies linking RFID chips to cancer in animals, although
Katherine Albrecht of Spychips.org had little trouble unearthing three
such studies at the Harvard medical library. When the AP asked if the
FDA had considered these or other studies before it approved the use
of implanatable chips, the agency declined repeated requests to
specify what studies it had reviewed for its decision.

The AP also uncovered an important connection between VeriChip and
former Health and Human Services Secretary Tommy Thompson, whose
agency oversaw the FDA while it was considering the VeriChip for
approval.

http://blog.wired.com/27bstroke6/200...-bulldog-.html


Two weeks after the device's approval took effect on Jan. 10, 2005,
Thompson left his Cabinet post, and within five months was a board
member of VeriChip Corp. and Applied Digital Solutions. He was
compensated in cash and stock options.

Thompson, until recently a candidate for the 2008 Republican
presidential nomination, says he had no personal relationship with the
company as the VeriChip was being evaluated, nor did he play any role
in FDA's approval process of the RFID tag.

"I didn't even know VeriChip before I stepped down from the Department
of Health and Human Services," he said in a telephone interview.

But the AP uncovered evidence that seems to suggest otherwise.


Thompson vigorously campaigned for electronic medical records and
healthcare technology both as governor of Wisconsin and at HHS. While
in President Bush's Cabinet, he formed a "medical innovation" task
force that worked to partner FDA with companies developing medical
information technologies.

At a "Medical Innovation Summit" on Oct. 20, 2004, Lester Crawford,
the FDA's acting commissioner, thanked the secretary for getting the
agency "deeply involved in the use of new information technology to
help prevent medication error." One notable example he cited: "the
implantable chips and scanners of the VeriChip system our agency
approved last week."

After leaving the Cabinet and joining the company board, Thompson
received options on 166,667 shares of VeriChip Corp. stock, and
options on an additional 100,000 shares of stock from its parent
company, Applied Digital Solutions, according to SEC records. He also
received $40,000 in cash in 2005 and again in 2006, the filings show.